Shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) have received a consensus rating of “Hold” from the eleven analysts that are presently covering the firm. One analyst has rated the stock with a sell …
BNS12h
Ariad Pharmaceuticals
Yamana Gold, Inc. has 52-Week high of $5.99 and 52-Week Low of $2.4. Axovant Sciences Ltd. (NYSE:AXON) said its drug nelotanserin has passed an early hurdle in a phase 2 study for Lewy body dementia, encouraging …
NASDAQ
Aria Networks will be on-site at Mobile World Congress at the ... In 2000 the company listed on the Shanghai Stock Exchange.
Aria Networks
The next stock is Ariad Pharmaceuticals Inc. (ARIA). This chart has a very appealing setup. You can see the stock has a well-defined uptrend that …
Stock Ideas
The tender offer for all of the outstanding shares of ARIAD common stock expired as scheduled, immediately following the offer’s expiration time of 11:59 p.m., Eastern Time, on February 15, 2017. Computershare Trust …
A News
On the other hand, bearish investors could view a new 52-week high as a signal of the end of a strong run, with the stock possibly peaking out before an impending period of decline. For ARIAD Pharmaceuticals Inc., the new …
Breaks
The tender offer for all of the outstanding shares of ARIAD common stock expired as scheduled, immediately following the offer’s expiration time of 11:59 p.m., Eastern Time, on February 15, 2017. Computershare Trust …
ARIAD Pharmaceuticals